viernes, 26 de octubre de 2018

Biogen's 'positive' Alzheimer's trial has a problem with small numbers - STAT

Biogen's 'positive' Alzheimer's trial has a problem with small numbers - STAT

Daily Recap

Biogen’s ‘positive’ Alzheimer’s trial has a problem with small numbers

By DAMIAN GARDE


NATIONAL INSTITUTE ON AGING, NIH
A presentation revealed that BAN2401's glimmer of promise is based on results from a small subset of patients in an otherwise large trial.

No hay comentarios:

Publicar un comentario